Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Christchurch green shell mussel extract found effective

Media release – July 26, 2012

Clinical trial finds Christchurch green shell mussel extract better than glucosamine


Aroma director Ben Winters Jr, left, and managing director Ben Winters at a mussel farm in the Marlborough Sounds

An Australian clinical study trial has found Christchurch-made green shell mussel extract product to be more beneficial for arthritic conditions than glucosamine.

Bromley-based manufacturer Aroma NZ Ltd sought a 12-week clinical trial involving 38 people undertaken by Queensland University to establish the benefits of their product.

Aroma director Ben Winters Junior said today they wanted to see how their green shell mussel power compared to glucosamine for people who suffered from joint pain and inflammation.

``People had been asking us to carry out clinical studies on our product so we went ahead with this significant landmark clinical trial,’’ he said.

``The excellent trial results just released to us show that our green shell mussel power works more rapidly and provides faster relief than glucosamine for the arthritis sufferers who took part in the trial. The study proved overwhelming that the aroma green shell mussel extract significantly helped reduce joint pain and increased joint mobility in patients.

``This was the result we were looking for and confirms that our green shell mussel product definitely contains significant anti-inflammatory properties.’’

Joint pain is so widespread throughout society and not just the elderly whom suffer from arthritis but also young people, sports people from injuries and many others.

The university’s primary clinical investigator in the trial Samantha Coulson confirmed today that the Christchurch green shell mussel powder ``worked quicker and provided better relief’’ than the glucosamine used in the trial.

Winters said Aroma was looking to spread the great results of our trial and improve the quality of life for both people and animals because they were facing demand increasing their products.

Aroma NZ has been producing various products for more than 50 years in Christchurch. Winters’s grandfather had an essences and flavourings business in Rotterdam which he further developed in Christchurch from 1961. They stepped into the health food business 25 years ago and today employ 20 people, processing mussel from the Marlborough Sounds.

As well as the mussel extract, they produce green shell mussel oil, shark cartilage powder, oyster powder, paua (abalone) powder, fish protein powder, chondroitin sulphate and marine collagen. Aroma NZ exports to 30 countries and the New Zealand market makes up just five percent of overall revenue.

``We are so encouraged by these new clinical results that we plan to carry out a larger clinical trials on 140 people with a double-blind placebo that will carry more weight when pitching to pharmaceutical companies,’’ Winters said.

``We have invested heavily in research and development and we work closely with the Queensland University and Plant and Food Research on our marine nutraceuticals. Providing solid clinical data sets us apart from our competition as well as being able to supply large volumes all year round. We are the largest freeze drying plant in the southern hemisphere with eight freeze driers.’’

The New Zealand Food Safety Authority audits Aroma NZ’s factory on a monthly basis which allows them to export worldwide. Strict microbiological and heavy metal limits are set in place ensuring only the highest quality freeze-dried health foods reach their consumers.

Ends


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Interest Rates: Wheeler Hikes OCR To 3% On Inflationary Pressures, Eyes Kiwi

Reserve Bank governor Graeme Wheeler lifted the official cash rate for the second time in as many months, saying non-tradable inflationary pressures were "becoming apparent" in an economy that’s picking up pace and he's watching the impact of a strong kiwi dollar on import prices. More>>

ALSO:

Scoop Business: Equity Crowd Funding Carries Risks, High Failure Rate

Equity crowd funding, which became legal in New Zealand this month, comes with a high risk of failure based on figures showing existing forays into social capital have a success rate of less than 50 percent, one new entrant says. More>>

ALSO:

Scoop Business: NZ Migration Rises To 11-Year High In March

The country gained a seasonally adjusted 3,800 net new migrants in March, the most since February 2003, said Statistics New Zealand. A net 400 people left for Australia in March, down from 600 in February, according to seasonally adjusted figures. More>>

ALSO:

Hugh Pavletich: New Zealand’s Bubble Economy Is Vulnerable

The recent Forbes e-edition article by Jesse Colombo assesses the New Zealand economy “ 12 Reasons Why New Zealand's Economic Bubble Will End In Disaster ”, seems to have created quite a stir, creating extensive media coverage in New Zealand. More>>

ALSO:

Thursday Market Close: Genesis Debut Sparks Energy Rally

New Zealand stock rose after shares in the partially privatised Genesis Energy soared as much as 18 percent in its debut listing on the NZX, buoying other listed energy companies in the process. Meridian Energy, MightyRiverPower, Contact Energy and TrustPower paced gains. More>>

ALSO:

Power Outages, Roads Close: Easter Storm Moving Down Country

The NZ Transport Agency says storm conditions at the start of the Easter break are making driving hazardous in Auckland and Northland and it advises people extreme care is needed on the regions’ state highways and roads... More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news